Resolution of Chest X-Ray Opacities in Patients with Ventilator-associated Pneumonia

E-ISSN： 2212-3989|18|1|23-28

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.18, Iss.1, 2018-03, pp. : 23-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ventilator-associated pneumonia: an overview

By DiCocco Jennifer M Croce Martin A

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1461-1467

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin in Patients with Early-Onset Ventilator-Associated Pneumonia

By Pea F.

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 589-598

Adis International

Access to resources Recommend Favorite

Antibiotic prophylaxis strategies in the prevention of ventilator-associated pneumonia

By Sirvent Josep-Maria Torres Antoni

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1345-1354

Informa Healthcare

Access to resources Recommend Favorite

Diagnosis, Management and Prevention of Ventilator-Associated Pneumonia: An Update

By Vincent Jean-Louis > Cianferoni Silvia

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1927-1944

Adis International

Access to resources Recommend Favorite

Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?

By Pea Federico

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 147-152

Adis International

Access to resources Recommend Favorite